FDA warns of bowel obstruction risk linked to GSK's Rotarix

09/22/2010 | Reuters

The FDA warned that Rotarix, a rotavirus vaccine by GlaxoSmithKline, might cause an increased risk of intussusception. The warning is based on preliminary data from a Mexican study involving infants. "Although the results are preliminary and will require further evaluation, FDA approved revised labeling to inform health care providers of this finding," according to the agency's website.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA